Covishield

Latest news and video coverage curated from trusted media outlets


0 shares	Share Tweet Save Post Send


AstraZeneca Withdraws COVID-19 Vaccine Globally, Days After Side Effect Confession in UK Court AstraZeneca has globally withdrawn its Covid vaccine, citing commercial reasons. The company voluntarily revoked its marketing authorization and announced the cessation of vaccine production, rendering.. Credit: Oneindia Duration: 05:11Published 3 days ago

Kya Covishield safe hai!!!(Hindi) In this video we will know about the astrazenica case Credit: Rumble Duration: 02:19Published 1 week ago

Covishield: Parents File Lawsuit Against Serum Institute Amid AstraZeneca’s Report\| Oneindia After AstraZeneca's acknowledgment of rare side effects, parents of a woman allegedly deceased post-Covishield vaccination initiated legal action against Serum Institute of India. Covishield, developed.. Credit: Oneindia Duration: 03:03Published 1 week ago

Lok Sabha Elections 2024: SP Chief Akhilesh Yadav Talks Exclusively with Oneindia in Mainpuri, UP Watch as Akhilesh Yadav addresses the crowd in Mainpuri, Uttar Pradesh, discussing key issues including unemployment, Covishield vaccination, and the call to end 'Agniveer'. He also highlights.. Credit: Oneindia Duration: 02:44Published 1 week ago

Side Effects Of COVID vaccine Covid 19 vaccine covishield side 6 Credit: Rumble Duration: 00:11Published 1 week ago

You Might Like

Covishield side effects: Doctors' group urges govt to review all Covid vaccines IndiaTimes - Published 15 hours ago
TOI Health News Morning Briefing SII ceased Covishield production due to decreased demand, focusing on Thrombosis transparency. Car cabin air contains carcinogens, impacting health. Vitamin D absorption hindered by various factors... IndiaTimes - Published 22 hours ago
Covishield side effects disclosed in packaging: SII Serum Institute of India stopped Covishield production due to reduced demand post high vaccination rates. They disclosed rare side effects like Thrombosis with thrombocytopenia syndrome since 2021,.. IndiaTimes - Published 2 days ago

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall UK-based drug major AstraZeneca's decision to withdraw its Covid-19 vaccine globally, days after admitting to side effects, prompted Serum Institute of India to disclose that it had stopped.. IndiaTimes - Published 2 days ago
'Manufacturing of Covishield ceased two years back due to poor demand' IndiaTimes - Published 2 days ago
SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert' SII stopped Covishield extra doses due to lawsuit, disclosed rare Thrombosis. Advocates govt collaboration. AstraZeneca withdraws Vaxzevria marketing authorisations globally. European Medicines Agency.. IndiaTimes - Published 2 days ago

Covishield Maker AstraZeneca Withdraws Covid-19 Vaccine Globally, Cites `Commercial Reason` According to AstraZeneca, the vaccination has been replaced by revised shots that address novel variations. Zee News - Published 3 days agoAlso reported by •DNA
AstraZeneca withdraws COVID vaccine worldwide AstraZeneca withdraws COVID vaccine worldwide due to TTS. Facing 100 million pound lawsuit. TTS involves blood clots, low platelets. Symptoms: severe headache, abdominal pain. Treatment: anticoagulant.. IndiaTimes - Published 3 days ago
Did you know Shreyas's heart stopped for 10 mins? Recent concerns regarding potential links between the Covishield vaccine and blood clots have sparked widespread discussion. Amidst this, Bollywood actor Shreyas Talpade shared his perspective, drawing.. IndiaTimes - Published 5 days ago
Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects Following AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine manufacturer.. IndiaTimes - Published 1 week ago

What is Covishield's rare side effect, TTS? Prominent vaccine manufacturer Astra Zeneca acknowledged in a court filing that TTS, a disorder that can result in blood clots and low platelet counts, can be brought on by the Covid vaccination. Many.. IndiaTimes - Published 1 week ago
AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be? In India, almost 90% of people who received Covid vaccine, received the AstraZeneca vaccine which in India is called Covishield. DNA - Published 1 week ago
AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concerns In light of recent concerns surrounding potential rare side effects of the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical giant has reiterated its commitment to patient safety while.. DNA - Published 1 week ago	AstraZeneca admits its COVID-19 vaccine Covishield can cause rare... Covishield was developed by AstraZeneca in collaboration with the Oxford University during the COVID-19 pandemic DNA - Published 2 weeks agoAlso reported by •IndiaTimes
Meet Pune's richest man with net worth of Rs 166500 crore, is founder of world's largest pharmaceutical company, he is.. He played a crucial role as the leader of the Serum Institute of India in the large-scale production of the Covishield vaccine amid the Covid-19 pandemic. DNA - Published on January 12, 2024	Take down defamatory posts on Covishield: Bombay high court IndiaTimes - Published on June 6, 2023
Bombay HC says content posted against Covishield vaccine prima facie defamatory The Bombay High Court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and.. Mid-Day - Published on June 5, 2023	Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HC The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and.. IndiaTimes - Published on June 5, 2023Also reported by •Mid-Day
SII to restart vaccine production amid surge in Covid cases Serum Institute of India CEO Adar Poonawalla told TOI on Wednesday that the company has resumed production of its Covid-19 vaccine, Covishield, in response to the increasing number of SARS-CoV-2 virus.. IndiaTimes - Published on April 12, 2023	Serum Institute of India restarts manufacturing of Covid-19 vaccine Covishield Serum Institute of India CEO Adar Poonawalla on Wednesday said the company has restarted manufacturing of Covid-19 vaccine Covishield amid rising numbers of cases of the virus infection. He said the.. IndiaTimes - Published on April 12, 2023
Record Breaking 'Hero' Gives Maximum Vaccine Doses, on Track to Beat the Pandemic India Book of Records strives to be a valuable resource of inspiration for people around the country, as it celebrates and honours the incredible feats and accomplishments of people in various fields.. NewsVoir - Published on April 11, 2023	Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose Covovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax.. IndiaTimes - Published on April 10, 2023
Booster dose of Covishield offers best immune response: Lancet study IndiaTimes - Published on January 25, 2023	Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults Covid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two.. Zee News - Published on January 18, 2023
UP gets fresh supply for Covishield vax doses newKerala.com - Published on January 18, 2023	Covid-19: Govt admits multiple side-effects of coronavirus vaccines in RTI reply In the reply to an RTI filed by a Pune businessman, ICMR and CDSCO have admitted to multiple side effects of Covid-19 vaccination and the Covishield which was among the first vaccines approved by.. Zee News - Published on January 16, 2023
Do you need 4th dose of COVID vaccine? The study was conducted on the participants who had received the booster dose of the Covishield vaccination. IndiaTimes - Published on January 13, 2023	Drug panel favours nod for Covovax as Covid booster An expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have.. IndiaTimes - Published on January 12, 2023
Covovax may get approval as heterologous booster The government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for.. IndiaTimes - Published on January 10, 2023	Covid-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla Serum Institute of India chief executive officer Adar Poonawalla on Sunday said its Covovax vaccine will get approval as a booster in the next 10 to 15 days, adding it works very well against the.. IndiaTimes - Published on January 8, 2023
Himachal seeks 10 lakh doses of Covishield newKerala.com - Published on January 5, 2023	Covid-19: Vaccination figures jump three-fold in Mumbai Govt-run centres only have Covaxin; state writes to Centre seeking Covishield, Corbevax Mid-Day - Published on December 30, 2022
Serum Institute to provide 2 crore Covishield doses to central govt free of cost IndiaTimes - Published on December 28, 2022	Bharat Biotech's nasal vaccine to be priced at Rs 800/dose in pvt markets, Rs 325/dose for governments Bharat Biotech on Tuesday said that its intranasal Covid-19 vaccine iNCOVACC will be priced at Rs 800 per dose for the private markets and Rs 325 per dose for central and state governments. The company.. IndiaTimes - Published on December 27, 2022
No shortage of Covishield, says Poonawalla IndiaTimes - Published on December 26, 2022	Noida residents experience vaccination shortage: Check where Covid-19 vaccine, booster dose are available Noida residents experienced shortage of Covaxin and Covishield on Saturday, check out where you can get Covid-19 vaccine and booster dose. DNA - Published on December 25, 2022
Explained: Covid-19 nasal vaccine available now, know how it works and who can take The nasal vaccine can be administered as a heterologous booster dose by people who have already received Covishield and Covaxin. DNA - Published on December 24, 2022	Adar Poonawallah`s IMPORTANT MESSAGE amid Covid outbreak in China Amid an alarming surge of Covid-19 cases in China, the CEO and founder of Serum Institute of India Adar Ponawalla in a tweet has urged the people not to panic. Serum Institute of India is the one who.. Zee News - Published on December 21, 2022
Mumbai: No takers, no stock for Covid-19 vaccines With interest waning, BMC has also run out of Covishield and Corbevax stock, with just a few thousand doses of Covaxin left Mid-Day - Published on December 13, 2022	Covishield vaccine complication: Kerala HC issues notice to SII, state, Centre newKerala.com - Published on November 18, 2022
People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO Adar Poonawalla "Since December 2021, we have stopped the production of the Covishield vaccine. We had a stock of a few hundred million doses at that time and of that 100 million doses had already expired," Poonawalla.. Zee News - Published on November 1, 2022	SII stopped production of Covishield vaccine since December 2021, says CEO Adar Poonwalla newKerala.com - Published on October 21, 2022

Covishield

Latest news and video coverage curated from trusted media outlets

You Might Like

Covishield side effects: Doctors' group urges govt to review all Covid vaccines

TOI Health News Morning Briefing

Covishield side effects disclosed in packaging: SII

Stopped producing Covishield in Dec 2021: SII after AstraZeneca recall

'Manufacturing of Covishield ceased two years back due to poor demand'

SII stopped manufacturing Covishield since December 2021, says 'disclosed side effects details in packaging insert'

Covishield Maker AstraZeneca Withdraws Covid-19 Vaccine Globally, Cites `Commercial Reason`

AstraZeneca withdraws COVID vaccine worldwide

Did you know Shreyas's heart stopped for 10 mins?

Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effects

What is Covishield's rare side effect, TTS?

AstraZeneca admits Covishield vaccines raises rare side-effects risk. How worried should you be?

AstraZeneca reaffirms COVID-19 vaccine Covishield safety amidst rare side effect concerns

AstraZeneca admits its COVID-19 vaccine Covishield can cause rare...

Meet Pune's richest man with net worth of Rs 166500 crore, is founder of world's largest pharmaceutical company, he is..

Take down defamatory posts on Covishield: Bombay high court

Bombay HC says content posted against Covishield vaccine prima facie defamatory

Content posted against Serum Institute of India, its Covishield vaccine prima facie defamatory: Bombay HC

SII to restart vaccine production amid surge in Covid cases

Serum Institute of India restarts manufacturing of Covid-19 vaccine Covishield

Record Breaking 'Hero' Gives Maximum Vaccine Doses, on Track to Beat the Pandemic

Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose

Booster dose of Covishield offers best immune response: Lancet study

Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adults

UP gets fresh supply for Covishield vax doses

Covid-19: Govt admits multiple side-effects of coronavirus vaccines in RTI reply

Do you need 4th dose of COVID vaccine?

Drug panel favours nod for Covovax as Covid booster

Covovax may get approval as heterologous booster

Covid-19: Covovax to get approval as booster in 10-15 days, says SII CEO Adar Poonawalla

Himachal seeks 10 lakh doses of Covishield

Covid-19: Vaccination figures jump three-fold in Mumbai

Serum Institute to provide 2 crore Covishield doses to central govt free of cost

Bharat Biotech's nasal vaccine to be priced at Rs 800/dose in pvt markets, Rs 325/dose for governments

No shortage of Covishield, says Poonawalla

Noida residents experience vaccination shortage: Check where Covid-19 vaccine, booster dose are available

Explained: Covid-19 nasal vaccine available now, know how it works and who can take

Adar Poonawallah`s IMPORTANT MESSAGE amid Covid outbreak in China

Mumbai: No takers, no stock for Covid-19 vaccines

Covishield vaccine complication: Kerala HC issues notice to SII, state, Centre

People fed up of Covid-19 pandemic, no takers for booster jabs: SII CEO Adar Poonawalla

SII stopped production of Covishield vaccine since December 2021, says CEO Adar Poonwalla